Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLD-2660 in Hospitalized COVID-19
NCT04334460Phase 2Completed
- Sponsor
- Blade Therapeutics, Inc.
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of dazcapistat in coronavirus disease 2019 (COVID-19), sponsored by Blade Therapeutics, Inc.. Started May 2020; status: completed.
02
Drugs
dazcapistat
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04334460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04334460.